Relationships between amiodarone dosage, drug concentrations, and adverse side effects☆
References (12)
- et al.
Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride
Am J Cardiol
(1974) - et al.
Rapid high-performance liquid chromatographic method for the measurement of amiodarone in blood plasma or serum at the concentrations attained during therapy
J Chromatogr
(1980) - et al.
Clinical efficacy of amiodarone as an antiarrhythmic agent
Am J Cardiol
(1976) - et al.
High-performance liquid chromatographic measurement of amiodarone and its desethyl metabolite: Methodology and preliminary observation
Ther Drug Monit
(1982) - et al.
Amiodarone kinetics after oral doses
Clin Pharmacol Ther
(1982) - et al.
Pharmacokinetics of amiodarone after intravenous and oral administration
Eur J Clin Pharmacol
(1981)
There are more references available in the full text version of this article.
Cited by (0)
- ☆
Supported in part by the Herman C. Krannert Fund, Indianapolis; by grants HL-06308 and HL-07182 from the National Heart, Lung and Blood Institute, National Institutes of Health; by the Attorney General of Indiana Public Health Trust; by the Roudebush Veterans Administration Medical Center, Indianapolis; and by a Grant-In-Aid from the American Heart Association, Indiana Affiliate, Inc.
Copyright © 1983 Published by Mosby, Inc.